Citadel Advisors
BMEZ icon

Citadel Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Citadel Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,677
Closed -$273K – 14279
2024
Q1 		$273K Sell
16,677
-12,721
-43% -$201K ﹤0.01% 9665
2023
Q4 		$431K Buy
+29,398
New +$410K ﹤0.01% 8423

Other funds holding BMEZ

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's BMEZ Position: Q2 2024 in Review

Citadel Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2024, closing a stake of 16,677 shares — an estimated $273K sold.

Citadel Advisors first reported a position in BMEZ in Q4 2023 and held it in 2 quarters. The position peaked at $431K in Q4 2023. 92 funds tracked by Wall St. Rank hold BMEZ as of Q2 2024.

  • Citadel Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 16,677 BlackRock Health Sciences Trust II shares in Q2 2024, an estimated $273K.
  • Citadel Advisors first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and held it in 2 quarters.
  • Citadel Advisors's BlackRock Health Sciences Trust II position peaked at $431K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.